PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)

M He, C Cao, Z Ni, Y Liu, P Song, S Hao, Y He… - … and Targeted Therapy, 2022 - nature.com
Abstract PROteolysis TArgeting Chimeras (PROTACs) technology is a new protein-
degradation strategy that has emerged in recent years. It uses bifunctional small molecules …

Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions

J Ma, Y Li, X Yang, K Liu, X Zhang, X Zuo… - Signal transduction and …, 2023 - nature.com
Hypertension is a global public health issue and the leading cause of premature death in
humans. Despite more than a century of research, hypertension remains difficult to cure due …

Structural basis of α1A-adrenergic receptor activation and recognition by an extracellular nanobody

Y Toyoda, A Zhu, F Kong, S Shan, J Zhao… - Nature …, 2023 - nature.com
The α1A-adrenergic receptor (α1AAR) belongs to the family of G protein-coupled receptors
that respond to adrenaline and noradrenaline. α1AAR is involved in smooth muscle …

G protein–dependent and G protein–independent signaling pathways and their impact on cardiac function

DG Tilley - Circulation research, 2011 - Am Heart Assoc
G protein-coupled receptors signal through a variety of mechanisms that impact cardiac
function, including contractility and hypertrophy. G protein–dependent and G protein …

Targeting aging and age-related diseases with vaccines

R Wu, F Sun, W Zhang, J Ren, GH Liu - Nature Aging, 2024 - nature.com
Aging is a major risk factor for numerous chronic diseases. Vaccination offers a promising
strategy to combat these age-related diseases by targeting specific antigens and inducing …

Updates in the function and regulation of α1‐adrenoceptors

J Akinaga, JA García‐Sáinz… - British journal of …, 2019 - Wiley Online Library
α1‐Adrenoceptors are seven transmembrane domain GPCRs involved in numerous
physiological functions controlled by the endogenous catecholamines, noradrenaline and …

The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect

K Pytka, K Podkowa, A Rapacz, A Podkowa… - Pharmacological …, 2016 - Elsevier
Depression is a serious global illness, becoming more and more common in developed
countries. Because of specific symptoms it is considered as a leading cause of disability all …

The pharmacology of α1-adrenoceptor subtypes

JR Docherty - European journal of pharmacology, 2019 - Elsevier
This review examines the functions of α 1-adrenoceptor subtypes, particularly in terms of
contraction of smooth muscle. There are 3 subtypes of α 1-adrenoceptor, α 1A-α 1B-and α …

Therapeutic potential of cone snail venom peptides (conopeptides)

I Vetter, RJ Lewis - Current topics in medicinal chemistry, 2012 - ingentaconnect.com
Cone snails have evolved many 1000s of small, structurally stable venom peptides
(conopeptides) for prey capture and defense. Whilst< 0.1% have been pharmacologically …

Sympathetic Nervous System and Atherosclerosis

Y Wang, J Anesi, MC Maier, MA Myers… - International journal of …, 2023 - mdpi.com
Atherosclerosis is characterized by the narrowing of the arterial lumen due to subendothelial
lipid accumulation, with hypercholesterolemia being a major risk factor. Despite the recent …